Chiyuki Okuda

740 total citations
33 papers, 592 citations indexed

About

Chiyuki Okuda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Chiyuki Okuda has authored 33 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Chiyuki Okuda's work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Chiyuki Okuda is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Chiyuki Okuda collaborates with scholars based in Japan, Canada and Italy. Chiyuki Okuda's co-authors include Katsuhiro Masago, Akito Hata, Reiko Kaji, Shiro Fujita, Yosuke Togashi, Yuichi Sakamori, Michiaki Mishima, Young Hak Kim, Nobuyuki Katakami and Nobuyuki Katakami and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Chiyuki Okuda

32 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiyuki Okuda Japan 14 350 298 107 84 82 33 592
Fabian Wolpert Switzerland 14 210 0.6× 202 0.7× 105 1.0× 38 0.5× 39 0.5× 30 494
A. Katzenwadel Germany 13 228 0.7× 122 0.4× 133 1.2× 46 0.5× 56 0.7× 23 548
Jame Abraham United States 11 476 1.4× 164 0.6× 71 0.7× 45 0.5× 34 0.4× 35 660
Francisco Martínez‐Ricarte Spain 15 168 0.5× 111 0.4× 174 1.6× 251 3.0× 68 0.8× 33 778
Yuan Yang China 13 60 0.2× 94 0.3× 172 1.6× 135 1.6× 56 0.7× 38 512
Elmar Heinrich Germany 15 328 0.9× 138 0.5× 110 1.0× 46 0.5× 21 0.3× 28 555
Narihiko Hayashi Japan 14 352 1.0× 138 0.5× 157 1.5× 67 0.8× 70 0.9× 45 582
Mary Welch United States 12 92 0.3× 108 0.4× 64 0.6× 57 0.7× 35 0.4× 37 405
Tom van den Ende Netherlands 12 168 0.5× 167 0.6× 117 1.1× 70 0.8× 38 0.5× 27 512
Refika Yigit Netherlands 10 218 0.6× 254 0.9× 54 0.5× 39 0.5× 46 0.6× 18 712

Countries citing papers authored by Chiyuki Okuda

Since Specialization
Citations

This map shows the geographic impact of Chiyuki Okuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiyuki Okuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiyuki Okuda more than expected).

Fields of papers citing papers by Chiyuki Okuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiyuki Okuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiyuki Okuda. The network helps show where Chiyuki Okuda may publish in the future.

Co-authorship network of co-authors of Chiyuki Okuda

This figure shows the co-authorship network connecting the top 25 collaborators of Chiyuki Okuda. A scholar is included among the top collaborators of Chiyuki Okuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiyuki Okuda. Chiyuki Okuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irie, Kei, Akira Okada, Yoshio Masuda, et al.. (2018). Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy. Journal of Oncology Pharmacy Practice. 25(4). 865–868. 1 indexed citations
2.
Masago, Katsuhiro, Shiro Fujita, Akito Hata, et al.. (2018). Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant EGFR mutant non‐small‐cell lung cancer. Pathology International. 68(3). 167–173. 6 indexed citations
3.
Hata, Akito, Nobuyuki Katakami, Shigeki Nanjo, et al.. (2017). Rebiopsy of Histological Samples in Pretreated Non-small Cell Lung Cancer: Comparison Among Rebiopsy Procedures. In Vivo. 31(3). 475–479. 7 indexed citations
4.
Nanjo, Shigeki, Akito Hata, Chiyuki Okuda, et al.. (2017). Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer. British Journal of Cancer. 118(1). 32–37. 69 indexed citations
5.
Hata, Akito, Nobuyuki Katakami, Shigeki Nanjo, et al.. (2017). Programmed death-ligand 1 expression and T790M status in EGFR -mutant non-small cell lung cancer. Lung Cancer. 111. 182–189. 33 indexed citations
6.
Hata, Akito, Nobuyuki Katakami, Shigeki Nanjo, et al.. (2016). Correlation between programmed death-ligand 1 (PD-L1) expression and T790M status in EGFR-mutant non-small cell lung cancer (NSCLC). Annals of Oncology. 27. vi428–vi428. 1 indexed citations
7.
Otsuka, Kyoko, Akito Hata, Jumpei Takeshita, et al.. (2015). EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 76(4). 835–841. 39 indexed citations
8.
9.
Fujita, Shiro, Katsuhiro Masago, Jumpei Takeshita, et al.. (2015). Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer. PLoS ONE. 10(6). e0130219–e0130219. 6 indexed citations
10.
Masago, Katsuhiro, Shiro Fujita, Miho Muraki, et al.. (2015). Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations. BMC Cancer. 15(1). 908–908. 27 indexed citations
11.
Togashi, Yosuke, Katsuhiro Masago, Isao Ito, et al.. (2012). Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer. Oncology Letters. 5(2). 601–604. 9 indexed citations
12.
Kim, Young Hak, Chiyuki Okuda, Yuichi Sakamori, et al.. (2012). Continuous morphine infusion for end-stage lung cancer patients. Oncology Letters. 5(3). 972–974. 5 indexed citations
13.
Togashi, Yosuke, Katsuhiro Masago, Yuichi Sakamori, et al.. (2011). Long-term Survival in a Patient with Small-cell Lung Cancer Undergoing Hemodialysis Who Received Multiple Courses of Chemotherapy. Japanese Journal of Clinical Oncology. 41(4). 582–585. 4 indexed citations
14.
Togashi, Yosuke, Katsuhiro Masago, Tomohiro Handa, et al.. (2011). Prognostic Significance of Preexisting Interstitial Lung Disease in Japanese Patients With Small-Cell Lung Cancer. Clinical Lung Cancer. 13(4). 304–311. 29 indexed citations
15.
Okuda, Chiyuki, Young Hak Kim, Kengo Takeuchi, et al.. (2011). Successful Treatment with Pemetrexed in a Patient with Mucinous Bronchioloalveolar Carcinoma: Long-Term Response Duration with Mild Toxicity. Journal of Thoracic Oncology. 6(3). 641–642. 4 indexed citations
16.
Sakamori, Yuichi, Young Hak Kim, Chiyuki Okuda, et al.. (2011). Two Cases of Cancer-associated Retinopathy Combined with Small-cell Lung Cancer. Japanese Journal of Clinical Oncology. 41(5). 669–673. 15 indexed citations
17.
Togashi, Yosuke, Katsuhiro Masago, Masahide Fukudo, et al.. (2011). Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation. Cancer Chemotherapy and Pharmacology. 68(4). 1089–1092. 65 indexed citations
18.
19.
Masago, Katsuhiro, Shiro Fujita, Yosuke Togashi, et al.. (2010). Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib. Oncology. 79(5-6). 355–362. 19 indexed citations
20.
Iida, Koji, Hiroshi Otsubo, Ismail Mohamed, et al.. (2005). Characterizing Magnetoencephalographic Spike Sources in Children with Tuberous Sclerosis Complex. Epilepsia. 46(9). 1510–1517. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabian Wolpert Breakdown of academic impact, for papers by A. Katzenwadel Breakdown of academic impact, for papers by Jame Abraham Breakdown of academic impact, for papers by Francisco Martínez‐Ricarte Breakdown of academic impact, for papers by Yuan Yang Breakdown of academic impact, for papers by Elmar Heinrich Breakdown of academic impact, for papers by Narihiko Hayashi Breakdown of academic impact, for papers by Mary Welch Breakdown of academic impact, for papers by Tom van den Ende Breakdown of academic impact, for papers by Refika Yigit
Rankless by CCL
2026